Introducing Mobile Collaborative Robots into Bioprocessing Environments: Personalised Drug Manufacturing and Environmental Monitoring
Source abstract
Abstract
Personalised therapeutic drugs are the future of the medical drug sector. For manufacturers, this will require the flexibility to produce many different unique batches within a given facility. This research paper aims to demonstrate the potential of mobile collaborative robots for improving current manufacturing practices in personalised therapeutics. The benefits and challenges of introducing robots in biologics are explored, including current practices, limitations, likely future practices, and the market outlook. Experiments demonstrating the application of a mobile collaborative robot to perform three different routine tasks is presented. These experiments include the transport of centrifugal tubes, manipulation of infusion bags, and scanning of Petri dishes for environmental monitoring. The investigations highlight the potential of collaborative mobile robotic platforms for automating the routine tasks carried out within the biomanufacturing sector.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Viral Infectious Diseases and Gene Expression in Insects · CAR-T cell therapy research · Biomedical and Engineering Education
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Laboratory for Advanced Manufacturing Simulation and Robotics (LAMS), School of Mechanical and Materials Engineering, University College Dublin, D04 V1W8 Dublin, Ireland
National Institute for Bioprocessing Research and Training, A94 X099 Dublin, Ireland
Funding
Enterprise Ireland funded project MARVIN · Irish Government and the European Union · PM Group Limited · Lonza Walkersville Inc. · Novartis Pharma AG
References (100+)
Show source-provided references
1. Schuster, S. (2021). COBOTS in Cleanrooms—The New Dimension of Automated Semiconductor Production, KUKA Deutschland GmbH.
2. Sandle, T. (2021, November 16). People in Cleanrooms: Understanding and Monitoring the Personnel Factor. Available online: https://www.ivtnetwork.com/article/people-cleanrooms-understanding-and-monitoring-personnel-factor.
3. The people factor: Investigating the gown
4. Origin of bacteria in the clean room and their growth requirements
5. Opportunities for Modern Robotics in Biologics Manufacturing
6. Miller, S., Zakharyevich, K., Kavanaugh, D., Lenich, R., Salim, J., Iles-Smith, P., Schelble, C., Sheehy, P., Merkle, S., and Beri, R. (2017). Biomanufacturing Technology Roadmap: 4. Automated Facilities, BioPhorum Operations Group, Ltd.
7. Stanton, D. (2022, March 13). The 4 Degrees of Automation in Cell Therapy Manufacture. Available online: https://bioprocessintl.com/bioprocess-insider/therapeutic-class/the-4-degrees-of-automation-in-cell-therapy-manufacture/?utm_medium=email&_hsmi=206184161&_hsenc=p2ANqtz-_26kfRxjy7VRDuc6uWRAcpaCQVkUqNZSsHBjPTBTftQxSo5WhBqNvBgBqo587pLd7WvCek1B0L6Wcy3W9Tmhxm.
8. A mobile robotic chemist10.1038/s41586-020-2442-2 ↗
9. Development of a multi camera calibration for an analysis and manipulation system of biological samples in petri dishes10.5194/isprs-archives-XLII-2-W18-67-2019 ↗
10. MIROB: Automatic rapid identification of micro-organisms in high through-put10.1108/01439910810876409 ↗
11. Microbiological validation of a robot for the sterile compounding of injectable non-hazardous medications in a hospital environment10.1136/ejhpharm-2018-001757 ↗
12. Takalo-Kippola, H., and Lappalainen, P. (1994, January 3–6). Novel laboratory robot for the manufacturing of microbiological culture media. Proceedings of the 16th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Baltimore, MD, USA.
13. U.S Food and Drug Administration (2022, June 03). Personalized Medicine: A Biological Approach to Patient Treatment, Available online: https://www.fda.gov/drugs/news-events-human-drugs/personalized-medicine-biological-approach-patient-treatment.
14. Kumar, K., and Kon, O.M. (2021). Personalised medicine for tuberculosis and non-tuberculous mycobacterial pulmonary disease. Microorganisms, 9.10.3390/microorganisms9112220 ↗
15. Strategies for integrating personalized medicine into healthcare practice10.2217/pme-2016-0064 ↗
16. Access for All: A Personalised Approach10.1159/000446529 ↗
17. Medicine in the early twenty-first century: Paradigm and anticipation—EPMA position paper 201610.1186/s13167-016-0072-4 ↗
18. Bioreactor design for clinical-grade expansion of stem cells10.1002/biot.201200373 ↗
19. Concise review: Guidance in developing commercializable autologous/patient-specific cell therapy manufacturing10.5966/sctm.2013-0050 ↗
20. A multiscale simulation framework for the manufacturing facility and supply chain of autologous cell therapies10.1016/j.jcyt.2019.07.002 ↗
21. Affordable biologics for all10.1001/jamanetworkopen.2020.4753 ↗
22. Toward a new framework for the development of individualized therapies10.1038/s41434-020-0143-y ↗
23. Evaluation of flexible automation for small batch production10.1016/j.promfg.2018.06.072 ↗
24. The path to personalized medicine10.1056/NEJMp1006304 ↗
25. Biomarkers and personalised medicine in rheumatoid arthritis: A proposal for interactions between academia, industry and regulatory bodies10.1136/ard.2011.154252 ↗
26. Path to personalized medicine for type 2 diabetes mellitus: Reality and hope
27. Personalized medicine: An overview
28. Allogeneic versus Autologous Stem-Cell Therapy
29. (2022, June 03). Precision Medicines: Adapting Manufacturing for Small Batch. Available online: https://www.theaccessgroup.com/en-gb/manufacturing/resources/pharma-insights/precision-medicines-adapting-manufacturing-for-the-super-small-batch/.
30. A guide to manufacturing CAR T cell therapies10.1016/j.copbio.2018.01.025 ↗
31. Bartel, R.L. (2015). Stem Cells and Cell Therapy: Autologous Cell Manufacturing. Translational Regenerative Medicine, Academic Press.10.1016/B978-0-12-410396-2.00008-6 ↗
32. Platforms for manufacturing allogeneic, autologous and iPSC cell therapy products: An industry perspective
33. Commercial scale manufacturing of allogeneic cell therapy10.3389/fmed.2018.00233 ↗
34. Schubert, H. (2022, March 03). The Challenges of Personalized Drugs—And Some Possible Solutions. Tech Talk. Available online: https://www.nne.com/techtalk/how-personalized-drugs-are-changing-pharma-manufacturing/.
35. Transportation conditions for prompt use of ex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration10.1089/ten.tec.2013.0250 ↗
36. Preservation of stem cells10.4161/org.5.3.9585 ↗
37. Optimizing the transport and storage conditions of current Good Manufacturing Practice –grade human umbilical cord mesenchymal stromal cells for transplantation (HUC-HEART Trial)10.1016/j.jcyt.2018.10.010 ↗
38. Draft of Iranian national guideline for cell therapy manufacturing
39. Design and development of a new ambr250Ò bioreactor vessel for improved cell and gene therapy applications10.1007/s10529-021-03076-3 ↗
40. Hematopoietic stem cells: From the bone to the bioreactor10.1016/S0167-7799(03)00076-3 ↗
41. Novel bioreactors for the culture and expansion of aggregative neural stem cells10.1007/s00449-007-0174-4 ↗
42. Expansion and Differentiation of Human Hematopoietic Cells from Static Cultures through Small-Scale Bioreactors10.1021/bp00020a600 ↗
43. Expansion of human bone marrow progenitor cells in a high cell density continuous perfusion system10.1038/nbt0393-368 ↗
44. Development of a fixed bed bioreactor for the expansion of human hematopoietic progenitor cells10.1023/A:1008085932764 ↗
45. Factorial designs combined with the steepest ascent method to optimize serum-free media for ex vivo expansion of human hematopoietic progenitor cells10.1016/S0141-0229(03)00144-3 ↗
46. Development of a production process for stem cell based cell therapeutic implants using disposable bioreactor systems10.1007/978-3-540-89208-3_546 ↗
47. Nienow, A.W., Coopman, K., Heathman, T.R.J., Rafiq, Q.A., and Hewitt, C.J. (2016). Bioreactor Engineering Fundamentals for Stem Cell Manufacturing, Elsevier.10.1016/B978-0-444-63265-4.00003-0 ↗
48. Strategies for the expansion of human induced pluripotent stem cells as aggregates in single-use Vertical-Wheel™ bioreactors10.1186/s13036-019-0204-1 ↗
49. (1999). Cleanrooms and Associated Controlled Environments—Part 1: Classification of Air Cleanliness (Standard No. ISO 14644-1:1999(en)). Available online: https://www.iso.org/obp/ui/#iso:std:iso:14644:-1:ed-1:v1:en.
50. Niazi, S.K. (2019). Handbook of Pharmaceutical Manufacturing Formulations, CRC Press. [3rd ed.]. Compressed Solid Products.10.1201/9781315103389 ↗
51. (2022, July 07). Tim Sandle Best Practices In Environmental Monitoring [White Paper]. Reading Scientific Services Ltd. Available online: https://www.researchgate.net/publication/342883006_Best_practices_in_environmental_monitoring.
52. Kuehn, S. (2022, March 09). Ascent of the Robots—Advancing Aseptic Proccessing through the Use of Robot Technology. Available online: https://www.pharmamanufacturing.com/articles/2015/ascent-of-the-robots/.
53. Kokubo, M., and Akers, J.E. (2016). Aseptic Manufacturing of Regenerative Medicine Products Using Isolator Technology, Springer.10.1007/978-4-431-55666-4_13 ↗
54. Evaluation of ultraviolet irradiation efficacy in an automated system for the aseptic compounding using challenge test10.1093/intqhc/mzv051 ↗
55. Key technologies and progress of pharmaceutical intelligent manufacturing production line
56. Media-fill simulation tests in manual and robotic aseptic preparation of injection solutions in syringes10.1177/1078155214565123 ↗
57. Spool production goes aseptic
58. Microbiological performance of a robotic system for aseptic compounding of cytostatic drugs10.1016/j.ejps.2019.01.034 ↗
59. Optimized Robot Systems for Future Aseptic Personalized Mass Production10.1016/j.procir.2018.03.066 ↗
60. Future Platforms of Robotic Surgery10.1016/j.ucl.2021.07.008 ↗
61. Emerging surgical robotic technology: A progression toward microbots10.21037/ales.2019.10.02 ↗
62. Robotic Developments in Cancer Surgery10.1016/j.soc.2018.07.003 ↗
63. The future medical science and colorectal surgeons10.3393/ac.2017.33.6.207 ↗
64. Jeon, H., Yang, K.-M., Park, S., Choi, J., and Lim, Y. (2018, January 27–31). An Ontology-based Home Care Service Robot for Persons with Dementia. Proceedings of the RO-MAN 2018—27th IEEE International Symposium on Robot and Human Interactive Communication, Nanjing, China.10.1109/ROMAN.2018.8525668 ↗
65. Salemi, B., Reis, J., Saifhashemi, A., and Nikgohar, F. (2005, January 2–6). MILO: Personal robot platform. Proceedings of the 2005 IEEE/RSJ International Conference on Intelligent Robots and Systems, IROS, Edmonton, AB, Canada.10.1109/IROS.2005.1545566 ↗
66. Yang, G., and Wang, S. (2019, January 4–7). Modeling and Control of a Personal Care Robot Considering Posture Adjustment. Proceedings of the 2019 IEEE International Conference on Mechatronics and Automation, ICMA 2019, Tianjin, China.10.1109/ICMA.2019.8816267 ↗
67. Digital health: A new dimension in rheumatology patient care10.1007/s00296-018-4037-x ↗
68. The role of disruptive technologies and approaches in ERAS®: Erupting change through disruptive means10.1007/s00423-022-02450-7 ↗
69. Ethically sound technology? Guidelines for interactive ethical assessment of personal health monitoring
70. Virk, G.S. (September, January 31). Personal care robot safety. Proceedings of the Emerging Trends in Mobile Robotics, 13th International Conference on Climbing and Walking Robots and the Support Technologies for Mobile Machines, CLAWAR 2010, Singapore.10.1142/9789814329927_0162 ↗
71. Villaronga, E.F., and Virk, G.S. (2017). Legal Issues for Mobile Servant Robots, Springer.10.1007/978-3-319-49058-8_66 ↗
72. Cleanroom robots become cleaner and more reliable10.1108/01439919810196928 ↗
73. Particle contamination below a robot arm in a cleanroom10.17764/jiet.2.36.5.dx782n4433225717 ↗
74. Robot design for wafer handling
75. Study on simulation of airflow within the enclosure in the semiconductor factory cleanroom10.1080/02786820500486003 ↗
76. Wolton, D. (2019). An Autonomous Sampling System. (16/333,765), U.S. Patent.
77. Towards robotic laboratory automation Plug & Play: The “LAPP” framework10.1016/j.slast.2021.11.003 ↗
78. Mixed reality interface for improving mobile manipulator teleoperation in contamination critical applications10.1016/j.promfg.2020.10.087 ↗
79. (2022, July 17). EI Marvin—Robotic Automation in the Biotechnology Sector—UCD Laboratory for Advanced Manufacturing Simulation and Robotics. Available online: https://www.ucd.ie/lams/research/projects/marvin/.
80. Optimization of fibrinogen isolation for manufacturing autologous fibrin glue for use as scaffold in tissue engineering10.3109/10731191003680748 ↗
81. (2022, March 07). Cell Separation and Cell Isolation: Techniques, Methods, Applications. Available online: https://www.stemcell.com/cell-separation.
82. (2022, March 07). Himac Practical Applications of Biological Centrifugation. Available online: https://www.himac-science.com/casebook/bio/bio-casebook.pdf.
83. An innovative, centrifugation-free method to prepare human platelet mediator concentrates showing activities comparable to platelet-rich plasma
84. Bespoke cell therapy manufacturing platforms10.1016/j.bej.2018.01.023 ↗
85. Co-culture of annulus fbrosus cells and bone marrow mesenchymal stem cells10.4238/2015.April.27.7 ↗
86. (2022, June 08). Applikon miniBio—Small Size Multi-Use Glass Autoclavable Bioreactor. Available online: https://www.getinge.com/int/products/applikon-minibio/.
87. Global Market Insights Inc (2022, March 10). Medical Fluid Bags Market. Available online: https://www.gminsights.com/industry-analysis/medical-fluid-bags-market.
88. LyondellBasell (2022, March 10). Infusion Bags. Available online: https://www.lyondellbasell.com/en/products-technology/polymers/application/infusion-bags/.
89. Stability study over time of clinical solutions of ziv-aflibercept prepared in infusion bags using a proper combination of physicochemical and functional strategies10.1016/j.jpba.2021.114209 ↗
90. Sorption of drugs by plastic infusion bags10.1016/0378-5173(82)90168-5 ↗
91. Urinary di-(2-ethylhexyl) phthalate metabolites for detecting transfusion of autologous blood stored in plasticizer-free bags10.1111/trf.13408 ↗
92. A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation10.1111/trf.15825 ↗
93. Packaging considerations for biopreservation10.1159/000326083 ↗
94. Evaluation of a novel Wave Bioreactor® cellbag for aerobic yeast cultivation10.1007/s00449-007-0119-y ↗
95. Kadwell, S.H., and Overton, L.K. (2016). Protein expression in insect and mammalian cells using baculoviruses in wave bioreactors. Baculovirus and Insect Cell Expression Protocols, Humana Press.10.1007/978-1-4939-3043-2_12 ↗
96. Improving wave-induced motion bioreactor performance for human mesenchymal stromal cell expansion10.1016/j.procbio.2019.06.004 ↗
97. Tsai, A.-C., and Pacak, C.A. (2021). Bioprocessing of human mesenchymal stem cells: From planar culture to microcarrier-based bioreactors. Bioengineering, 8.10.3390/bioengineering8070096 ↗
98. In support of settle plates
99. Examination of the exposition time of settle plates for monitoring sterile production areas | Untersuchungen zur verwendungsdauer von sedimentationsplatten bei der überwachung steriler fertigungsbereiche
100. Active air vs. passive air (settle plate) monitoring in routine environmental monitoring programs